Opinion

Video

Bispecific therapy – management of long-term adverse events in the community setting

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    What are challenges that you foresee for management of longer-term AEs in the community setting and how can they be addressed? What is the impact of AEs on treatment completion rates?

    Hypogammaglobulinemia (Baird JH et al. Blood Adv. 2021; 5(1):143-155. )

    Cytopenias (Jain T et al. Blood. 2023;141(20):2460-2469.)

    Infection (Hill JA et al. Blood. 2020; 136(8):925-935.)

    Newsletter

    Stay up to date on the most recent and practice-changing oncology data

    Related Content